Chinese vaccine lab to move into KC Animal Health Corridor

Jinyu Bio-technology Co. will open a vaccine research lab and office and partner with Kansas State University, the City of Manhattan and the State of Kansas to develop new animal health products

By Veterinary Practice News Editors

KC Animal Health Corridor of Kansas City, Mo., will soon be getting some new neighbors in its new K-State Office Park Phase II building.

That’s because Jinyu Bio-technology Co., Ltd. (also known as Jinyu Corp), has announced will open a vaccine research lab and office in the new building in 2018. The company will focus its Corridor location on research and design of vaccines for swine and cattle, as well as continuing education materials for Chinese companies and veterinarians.

“Manhattan and Kansas State University are at the forefront of animal health research that is relevant to the Chinese animal agriculture industry and the world,” said Chongyu Zhang, chairman of Jinyu Bio-technology Co., Ltd. “Jinyu is the largest animal vaccine company in China and is fast growing internationally. We are looking forward to developing a long-term, mutually beneficial relationship with partners in the region.”

Jinyu USA will partner with Kansas State University, the City of Manhattan and the State of Kansas to develop new animal health products that can be marketed in China, Asia, Africa and the U.S. The company is also considering the addition of future manufacturing facilities in the Corridor.

“The addition of Jinyu Bio-technology to the KC Animal Health Corridor is truly a partnership of innovation and expertise,” said Kansas Commerce Secretary Antonio Soave. “We, as a state, must continue to engage excellent biotech companies like Jinyu, as Kansas continues to become one of the leading locations for bioscience in the nation.”

Jinyu plans a 2,400-sq. ft. lab facility, three offices and 800-square-feet of clean room space at the K-State Office Park Phase II building, employing four to six scientific researchers. The KSU Foundation will break ground on the Phase II building in July 2017 and the company’s space will become available in 2018.

“When university-focused companies like Jinyu Bio-technology Co., Ltd., locate adjacent to K-State’s campus, partnerships develop with faculty expertise and research to promote real-world application and discovery,” said Greg Willems, KSU Foundation president and CEO. “The K-State Office Park advances opportunity for these current and future collaborations to boldly move K-State — and the needs of a global community — forward.”

This is the first partnership KSU has had with a Chinese company, said Jishu Shi, professor and director of the U.S. China Center for Animal Health at Kansas State University. “It will accelerate the commercialization of novel discovery and development generated by K-State scientists.”

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *